HIV感染中肥胖与脂肪肥大的识别与管理实用综述
该综述基于共识意见,阐述接受抗逆转录病毒治疗(ART)的HIV感染成人中肥胖与脂肪肥大的诊断、临床后果和治疗。肥胖与脂肪肥大常见且病理生理可能重叠,传统、HIV特异性及ART特异性风险因素均参与。过度脂肪的代谢和炎症后果是非AIDS事件的关键驱动因素,积极诊断与管理对预防终末器官疾病至关重要。
要点
- 接受ART的HIV感染成人中肥胖与脂肪肥大常见,病理生理可能重叠。
- 传统、HIV特异性及ART特异性风险因素共同促发过度脂肪积累。
- 过度脂肪的代谢和炎症后果是非AIDS事件的关键驱动因素。
核心结论
- 肥胖与脂肪肥大在接受ART的HIV感染者中普遍存在。
- 积极诊断与管理是预防和治疗终末器官疾病的关键。
研究设计与样本
- 共识意见,针对接受治疗的HIV感染成人的过度脂肪积累。
主要发现
- 肥胖与脂肪肥大常见,病理生理可能重叠和/或代谢后果协同。
- 传统、HIV特异性及ART特异性风险因素均参与。
- 过度脂肪的代谢和炎症后果是非AIDS事件的关键驱动因素。
临床怎么用
- 对接受ART的HIV感染者应积极诊断和管理肥胖与脂肪肥大。
- 关注过度脂肪的代谢和炎症后果以预防非AIDS事件和终末器官疾病。
局限性
- 需要进一步研究以更好理解现代ART时代肥胖与脂肪肥大的病理生理和最佳治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity and lipohypertrophy are common in treated human immunodeficiency virus (HIV) infection and contribute to morbidity and mortality among HIV-infected adults on antiretroviral therapy (ART). METHODS: We present a consensus opinion on the diagnosis, clinical consequences, and treatment of excess adiposity in adults with treated HIV infection. RESULTS: Obesity and lipohypertrophy commonly occur among HIV-infected adults on ART and may have overlapping pathophysiologies and/or synergistic metabolic consequences. Traditional, HIV-specific, and ART-specific risk factors all contribute. The metabolic and inflammatory consequences of excess adiposity are critical drivers of non-AIDS events in this population. Although promising treatment strategies exist, further research is needed to better understand the pathophysiology and optimal treatment of obesity and lipohypertrophy in the modern ART era. CONCLUSIONS: Both generalized obesity and lipohypertrophy are prevalent among HIV-infected persons on ART. Aggressive diagnosis and management are key to the prevention and treatment of end-organ disease in this population and critical to the present and future health of HIV-infected persons.
引用
- Lake JE, Stanley TL, Apovian CM, et al. Practical Review of Recognition and Management of Obesity and Lipohypertrophy in Human Immunodeficiency Virus Infection. Clin Infect Dis. 2017. PMID: 28329372. doi:10.1093/cid/cix178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。